Literature DB >> 6148992

Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea.

N S Williams, J C Cooper, A T Axon, R F King, M Barker.   

Abstract

A woman presented with persistent ileostomy diarrhoea unresponsive to conventional drug treatment and necessitating parenteral nutrition. Output was four to six litres of watery fluid per 24 hours while she was receiving oral nutrition and two to three litres when she was starved. Treatment with a long acting analogue of somatostatin (50 micrograms subcutaneously every 12 hours) reduced the ileostomy output to 2.0-2.5 litres/24 hours with an oral diet and the effluent became semiformed. Parenteral fluids could be stopped. Somatostatin may have a role in the treatment of secretory diarrhoea, but prospective controlled trials are necessary.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148992      PMCID: PMC1443040          DOI: 10.1136/bmj.289.6451.1027

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  2 in total

1.  Somatostatin decreases diarrhea in patients with the short-bowel syndrome.

Authors:  K Dharmsathaphorn; F S Gorelick; R S Sherwin; S Cataland; J W Dobbins
Journal:  J Clin Gastroenterol       Date:  1982-12       Impact factor: 3.062

2.  Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.

Authors:  A Ruskoné; E René; J A Chayvialle; N Bonin; F Pignal; M Kremer; S Bonfils; J C Rambaud
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

  2 in total
  20 in total

Review 1.  Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

Authors:  L J O'Donnell; M J Farthing
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

Review 2.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

Review 3.  The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective.

Authors:  Palle Bekker Jeppesen
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

Review 4.  Comprehensive care of the patient with gut failure: present and future.

Authors:  C R Fleming
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

5.  Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage.

Authors:  E Köhler; M Duberow-Drewe; J Drewe; G Ribes; M M Loubatiéres-Mariani; N Mazer; K Gyr; C Beglinger
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Effect of a new long-acting somatostatin analogue (SMS 201-995) on glycemic and hormonal response to a mixed meal in acromegalic patients.

Authors:  R Candrina; A Gussago; G Giustina
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

Review 7.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

8.  Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.

Authors:  K Ladefoged; K C Christensen; J Hegnhøj; S Jarnum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

Review 9.  Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.

Authors:  M J Farthing
Journal:  Gut       Date:  1994       Impact factor: 23.059

10.  Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.

Authors:  H S Füessl; W G Zoller; M M Kochen; J R Bogner; B Heinrich; A Matuschke; F D Goebel
Journal:  Klin Wochenschr       Date:  1989-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.